Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
Dose components determined for boron neutron capture therapy
April 22nd, 2003
Dose components of boron neutron capture therapy for treating brain cancer and melanoma were done on a head model. According to recent research from Brazil, "Application of neutrons to cancer treatment has been a subject of considerable clinical and research interest since the discovery of the neutron by Chadwick in 1932. "Boron neutron capture therapy (BNCT) is a technique which is used in treating brain cancer (glioblastoma multiform) or melanoma and that consists of preferentially loading a compound containing B10 into the tumor location, followed by the irradiation of the patient with a neutron beam. Dose distribution for BNCT is...
Source: Cancer Weekly (2003-04-22)
|
